Products
IP Intelligence Reports
Patexia Concierge
Patent Analyzer
Trademarks Analyzer
Litigation Analyzer
All Products
Services
Lateral Opportunities
Expert Witness
Research Studies
Strategic Partnership
All Services
IP Community
IP Community
IP Webinars
In the News
Company
About Us
Press Release
Careers
Contact Us
Login
Join
Book a Meeting
Back to All Articles
Browse articles with tag: Life Sciences
You must be logged in to create a new article
All Articles
Knobbe Martens
Apr 15, 2024
•
ANDA Litigation
Enter TitMedicare Drug Price Negotiation Program Steadily Progressing Despite Lawsuitsle
Written by: Brianne M. Kingery & Jason J. Jardine The Biden Administration’s Inflation Reduction Act (IRA)’s Medicare drug price negotiation program,...
Read More
0 Likes
0 Favorites
0 Comments
Knobbe Martens
Mar 25, 2024
•
Patent Prosecution
USPTO Issues Training Materials to Examiners for Searching FDA and NIH Resources
Written by: Ashley C. Morales & Joseph Mallon, Ph.D. On March 20, 2024, The USPTO issued an alert, notifying practitioners that...
Read More
0 Likes
0 Favorites
0 Comments
Knobbe Martens
Mar 18, 2024
•
ANDA Litigation
Antitrust Lawsuit Brought Against Drug Manufacturer Based on Its Allegedly Improper Listing of Device Patents in the FDA’s Orange Book
Written by: Ari Feinstein & Jane Dai, Ph.D. As we recently discussed, the Federal Trade Commission (“FTC”) sent warning letters to...
Read More
0 Likes
0 Favorites
0 Comments
Knobbe Martens
Feb 29, 2024
•
Patent Prosecution
Introduced Patent Eligibility Restoration Act of 2023 (PERA) Seeks to Revitalize Patent Eligibility Standards
Written by: Jacob J. Golan, Ph.D. & Jason J. Jardine On June 6, 2023, the Senate Judiciary Committee's Subcommittee on Intellectual...
Read More
1 Likes
0 Favorites
0 Comments
Knobbe Martens
Jan 25, 2024
•
ANDA Litigation
USPTO Says Wands Still Controls Enablement Analysis Post-Amgen
Written by: Rhett D. Ramsey & Eric Furman, Ph.D. On January 9, 2024, the USPTO published guidelines for its patent examiners...
Read More
0 Likes
0 Favorites
0 Comments
Knobbe Martens
Dec 18, 2023
•
Featured
ANDA Litigation
The FDA Approves Two New Gene Therapies for the Treatment of Sickle Cell Disease
Written by: Ashley C. Morales & Jane Dai, Ph.D. On December 8, 2023, the U.S. Food and Drug Administration (FDA) approved...
Read More
0 Likes
0 Favorites
0 Comments
<
1
2
3
4
>
Mikele Bicolli
Apr 19, 2024
•
Patent Prosecution
USPTO Proposes Patent Fee Adjustments for FY 2025
The United States Patent and Trademark Office (USPTO) is proposing adjustments to patent fees for fiscal year 2025. These changes,...
Read More
1 Likes
0 Favorites
0 Comments
Featured